| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/04/2006 | CA2179284C Substituted unsymmetrical cyanine dyes with selected permeability |
| 04/04/2006 | CA2087042C Genomic mapping method by direct haplotyping using intron sequence analysis |
| 04/01/2006 | CA2483570A1 Reagent system and process for adenosine triphosphate monitoring |
| 03/30/2006 | WO2006034431A2 Genetic selection of small molecule modulators of protein-protein interactions |
| 03/30/2006 | WO2006034427A2 Diagnosis of fetal aneuploidy |
| 03/30/2006 | WO2006034417A2 Trivalent metal mediated homogeneous luminescent proximity assay |
| 03/30/2006 | WO2006034387A1 TWO-COLOR REAL-TIME/END-POINT QUANTITATION OF MICRORNAS (miRNAs) |
| 03/30/2006 | WO2006034370A2 Systems and methods for evaluating enzyme competency |
| 03/30/2006 | WO2006034356A2 Cardiac pressure overload associated genes |
| 03/30/2006 | WO2006034349A2 Dna fingerprinting using a branch migration assay |
| 03/30/2006 | WO2006034332A2 In vivo incorporation of alkynyl amino acids into proteins in eubacteria |
| 03/30/2006 | WO2006034321A2 Oligomeric compounds effecting drosha-mediated cleavage |
| 03/30/2006 | WO2006034319A2 Porcine reproductive and respiratory syndrome isolates and methods of use |
| 03/30/2006 | WO2006034294A1 Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture |
| 03/30/2006 | WO2006034292A2 Antibodies against and methods for producing vaccines for respiratory syncytial virus |
| 03/30/2006 | WO2006034264A2 Methods of using sulfur nucleophiles as improved alternatives to sodium bisulfite for methylated dna analysis |
| 03/30/2006 | WO2006034215A2 Multiple mode multiplex reaction quenching method |
| 03/30/2006 | WO2006034188A2 Compositions and methods for obesity screening using polymorphisms in npy2r |
| 03/30/2006 | WO2006034064A2 Process for sterilization of and cyanoacrylate adhesive compositions and devices |
| 03/30/2006 | WO2006034036A1 Fluorescent dye compounds, conjugates and uses thereof |
| 03/30/2006 | WO2006034009A2 Purification of biomolecules from contaminating intact nucleic acids |
| 03/30/2006 | WO2006033962A2 Nonlinear spectroscopic methods for identifying and characterizing molecular interactions |
| 03/30/2006 | WO2006033933A2 Antisense antiviral compound and method for treating ssrna viral infection |
| 03/30/2006 | WO2006033843A2 Lanthanide-based substrates and methods for determining clostridial toxin activity |
| 03/30/2006 | WO2006033769A2 Assays and compositions for identification of cancer associated liver stem cells |
| 03/30/2006 | WO2006033768A2 Hcv multiple epitope fusion antigens with modified proteolytic cleavage sites and uses thereof |
| 03/30/2006 | WO2006033696A2 High density ion transport measurement biochip devices and methods |
| 03/30/2006 | WO2006033691A2 Copy choice recombination and uses thereof |
| 03/30/2006 | WO2006033665A1 Tat-based vaccine compositions and methods of making and using same |
| 03/30/2006 | WO2006033664A1 Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| 03/30/2006 | WO2006033484A1 Nucleic acid microarray and nucleic acid probe designing method, and method of gene detection |
| 03/30/2006 | WO2006033460A1 Method for diagnosing non-small cell lung cancers by trna-dihydrouridine synthase activity of urlc8 |
| 03/30/2006 | WO2006033409A1 Method of assaying anti-hcv agent with use of cyclophilin |
| 03/30/2006 | WO2006033400A1 Dna detection method and reporter probe |
| 03/30/2006 | WO2006033387A1 Method of detecting gene governing allergic predisposition |
| 03/30/2006 | WO2006033384A1 Dna oligomer, gene marker and dna oligomer set for predicting the onset of side effect in radiotherapy and method of predicting the onset of side effect |
| 03/30/2006 | WO2006033348A1 Labeling enzyme |
| 03/30/2006 | WO2006033020A2 Methods and apparatus for the detection and validation of micrornas |
| 03/30/2006 | WO2006032912A1 Treatment of spongiform encephalopathy by increased hydrogen peroxide degradation |
| 03/30/2006 | WO2006032859A2 Treatment of schizophrenia or suicidal behaviour with a 5-ht2c receptor antagonist |
| 03/30/2006 | WO2006032838A1 Glycosyltransferase assay |
| 03/30/2006 | WO2006032810A1 Method for detecting streptococcus agalactiae using ?-glucosidase activity |
| 03/30/2006 | WO2006032809A2 Method for detecting streptococcus agalactiae using esterase activity |
| 03/30/2006 | WO2006032769A1 Biochip for diagnosis of the metastatic or localized character of a mammary tumour, method and kit for use |
| 03/30/2006 | WO2006032542A1 Strain of lactobacillus acidophilus having analgesic properties in the gastrointestinal system |
| 03/30/2006 | WO2006032392A2 Uses of carbamoyl phosphate synthetase 1 (cps 1) as a humoral biomarker for the diagnosis of tumour diseases and chronic inflammatory intestinal diseases |
| 03/30/2006 | WO2006032158A1 Electrochemical patterning on multi-channel microelectrode array for biosensing applications |
| 03/30/2006 | WO2006015369A9 Assays for identification of topoisomerase inhibitors |
| 03/30/2006 | WO2006013016A3 Diagnostics and therapeutics for diseases associated with eosinophil serine protease 1 (prss21) |
| 03/30/2006 | WO2006013015A3 Diagnostics and therapeutics for diseases associated with marapsin (mpn) |
| 03/30/2006 | WO2006012451A3 Compositions and methods of use for mgd-csf in disease treatment |
| 03/30/2006 | WO2006010499A3 Diagnostics and therapeutics for diseases associated with carboxypeptidase a2 (cpa2) |
| 03/30/2006 | WO2006008656A3 Oatp-c gene c463a polymorphism underlies variable response of statin therapy |
| 03/30/2006 | WO2006008142A8 Diagnosis and therapy of psoriasis vulgaris |
| 03/30/2006 | WO2006008126A3 Novel use of the kinases rsk4 and pak5 |
| 03/30/2006 | WO2006007567A3 Methods and compositions to detect nucleic acids in a biological sample |
| 03/30/2006 | WO2006003638A3 Novel method for labeling nucleic acid in a sequence-specific manner, and method for detecting nucleic acid using the same |
| 03/30/2006 | WO2005123962A9 Gene targeting in eukaryotic cells by group ii intron ribonucleoprotein particles |
| 03/30/2006 | WO2005123929A3 Plastid transit peptides |
| 03/30/2006 | WO2005123048A3 Screening methods using c-abl, fyn and syk in combination with tau protein |
| 03/30/2006 | WO2005116265A3 Probe arrays for expression profiling of rat genes |
| 03/30/2006 | WO2005115458A3 Methods and compositions related to regulation of nucleo-cytoplasmic localization of e1 dna helicase in papillomaviruses |
| 03/30/2006 | WO2005108618A3 Methods and kits for methylation detection |
| 03/30/2006 | WO2005108614A3 Reversible and chemically programmable micelle assembly with dna block-copolymer amphiphiles |
| 03/30/2006 | WO2005105838A3 Ion channel |
| 03/30/2006 | WO2005103710A3 Diagnostics and therapeutics for diseases associated with corticotropin releasing hormone receptor 1 (crhr1) |
| 03/30/2006 | WO2005095956A3 Diagnostics and therapeutics for diseases associated with megakaryocyte-associated tyrosine-protein kinase |
| 03/30/2006 | WO2005073409A3 Methods, compositions, and kits for amplifying and sequencing polynucleotides |
| 03/30/2006 | WO2005072112A3 Methods for producing and identifying multispecific antibodies |
| 03/30/2006 | WO2005068612A3 Human hepatic progenitor cells and methods of use thereof |
| 03/30/2006 | WO2005062040A3 Method and system for analyzing reactions using an information system |
| 03/30/2006 | WO2005061720A3 High lysine maize compositions and methods for detection thereof |
| 03/30/2006 | WO2005047546A3 Diagnostic and prognostic methods and compositions for seizure- and plasticity-related disorders |
| 03/30/2006 | WO2005042767A3 Compositions and methods for detecting severe acute respiratory syndrome coronavirus |
| 03/30/2006 | WO2005040074A3 Crick-watson base paired dendrimer structures |
| 03/30/2006 | WO2005031305A3 Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules |
| 03/30/2006 | WO2005023983A3 Genes having lineage specific variations in copy number and methods of identifying same |
| 03/30/2006 | WO2005002417A3 Cancer -linked gene aas target for chemotherapy |
| 03/30/2006 | WO2005001046A3 Methods for predicting the course of a malignant disease |
| 03/30/2006 | WO2004090114A3 Compositions and methods of using a synthetic dnase i |
| 03/30/2006 | WO2004065932A3 Methods of identifying modulators of cellular glycosylation using gtrap3-18 |
| 03/30/2006 | WO2004059003A3 Incorporation of hapten groups during the production of carriers for the determination of analytes |
| 03/30/2006 | WO2004053071A3 Method for discovering neurogenic agents |
| 03/30/2006 | WO2004048594A3 Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences |
| 03/30/2006 | WO2004039943A3 Human genes and gene expression products isolated from human prostate |
| 03/30/2006 | WO2003105783A3 Cancer-linked gene as target for chemotherapy |
| 03/30/2006 | WO2003062369A3 Expansion of renewable stem cell populations |
| 03/30/2006 | WO2003014294A3 Tacis and br3 polypeptides and uses thereof |
| 03/30/2006 | US20060070139 Corn event DAS-59122-7 and methods for detection thereof |
| 03/30/2006 | US20060070136 GLYT1 transgenic mouse |
| 03/30/2006 | US20060070135 Compositions and methods for inhibiting the enzymatic activity of PTP-1B |
| 03/30/2006 | US20060070134 Diagnosis and treatment of fanconi's anemia |
| 03/30/2006 | US20060069518 Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation |
| 03/30/2006 | US20060069246 Tumor necrosis factor receptor related proteins Tango-63d and Tango-63e |
| 03/30/2006 | US20060069245 Screening methods for cognitive enhancers |
| 03/30/2006 | US20060069242 Neurotrophic factor receptor |
| 03/30/2006 | US20060069054 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/30/2006 | US20060069049 Methods and reagents related to foxo |
| 03/30/2006 | US20060069025 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 03/30/2006 | US20060068497 Methods for isolating novel antimicrobial agents from hypermutable mammalian cells |